As a worldwide leader in the field of haemostasis, Stago is setting the standard of excellence in the field, with cutting-edge technologies, products and customer service providing a complete laboratory haemostasis package.
Stago has earned a worldwide reputation for quality and scientific excellence in coagulation since the global company was first established in France almost 70 years ago. Research and development (R&D) underpin its success, with its technology seen as setting the ‘gold standard’ for haemostasis. It is one of the few companies in the world that has developed its in-house research and development capability to be able to design, develop and manufacture its own haemostasis reagents, consumables and analysers.
While most diagnostic companies invest 8–9% of turnover in research and development, Stago spends almost 13%. The result has been an expanding range of products, the latest of which is the next-generation STA-R Max analyser, set for launch in early 2015. Stago systems are designed to operate together, and with other analysers, to create a single system for maximum laboratory performance and efficiency.
Now distributed in over 110 countries, Stago opened its UK business less than 10 years ago, operating from a base in the M4 corridor, in Theale, Berkshire. Starting with a single engineer in 2005, this most recent entrant to the UK haemostasis market has developed from a regional office to a company in its own right, with over 250 systems operating in NHS and private laboratories.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.